STERIS STE Capital equipment — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by STERIS in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about STERIS's capital equipment — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is STERIS's capital equipment — revenue?
- STERIS (STE) reported capital equipment — revenue of $387M in Q1 2026.
- How has STERIS's capital equipment — revenue changed year-over-year?
- STERIS's capital equipment — revenue increased by 4.3% year-over-year, from $370.9M to $387M.
- What is the long-term trend for STERIS's capital equipment — revenue?
- Over 4 years (2022 to 2026), STERIS's capital equipment — revenue has grown at a 12.5% compound annual growth rate (CAGR), from $782.51M to $1.25B.
- What does capital equipment — revenue mean?
- This metric represents the total net sales generated from the sale of large-scale decontamination, sterilization, and infection prevention equipment to healthcare providers and biopharmaceutical manufacturers. It reflects the company's ability to capture market share in the high-value equipment cycle, which is often driven by facility expansion, regulatory compliance upgrades, and infrastructure modernization. As a primary revenue stream, it indicates the health of the company's core hardware business and its ability to secure long-term service and consumable contracts.